Arcutis Biotherapeutics Inc

NASDAQ:ARQT  
34.13
+1.51 (+4.63%)
Earnings Announcements

Arcutis Announces Q1 2021 Financial Results And Provides Business Update

Published: 05/04/2021 21:21 GMT
Arcutis Biotherapeutics Inc (ARQT) - Arcutis Announces First Quarter 2021 Financial Results and Provides Business Update.
Q1 Loss per Share $0.76.
Arcutis Biotherapeutics - Financial Position With Over $440 Million in Cash, Cash Equivalents & Marketable Securities Providing Cash Runway Well Into 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.02

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.25

More details on our Analysts Page.